MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...
AfroTech on MSN
Emma Grede Launched SKIMS In 2019 Alongside Kim Kardashian —Now It’s Worth $5B After Raising $225M In New Funding Round
The post Emma Grede Launched SKIMS In 2019 Alongside Kim Kardashian —Now It’s Worth $5B After Raising $225M In New Funding Round appeared first on AfroTech. The post Emma Grede Launched SKIMS In 2019 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback